Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Colin Baigent discusses how the benefits outweigh the hazards of Cholesterol-lowering drugs.

The largest and most reliable study ever to examine the effect of statins has found them to reduce the risk of heart attacks, strokes and premature deaths among a wide range of apparently healthy people. The benefits greatly exceed any known risks associated with taking these drugs.

Read more in this BBC News article: NHS 'should consider giving statins to healthy people'

Read the press release

Colin Baigent: Cholesterol-lowering drugs

Prof Colin Baigent discusses how the benefits outweigh the hazards of Cholesterol-lowering drugs.

This podcast presents the research done by Professor Colin Baigent whilst working in the Nuffield Department of Medicine. Professor Baigent now works at the Nuffield Department of Population Health.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.